BPA for ryplazim

Active Awarded Last action

Contract number
36E79723A0007
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Last date to order 78% complete
IDV ceiling
$6,358,550.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The National Acquisition Center awarded a Blanket Purchase Agreement to Kedrion Biopharma Inc. on December 6, 2022, against the Pharmaceuticals and Drugs (FSS-61-IB) Master GSA Schedule, for Ryplazim, a therapy for plasminogen deficiency type 1.

This is a single-award BPA with no set-aside used. The ceiling value is $6.36 million. The government description records the exercise of option year 4, and the ultimate completion date is December 5, 2027.

Transactions

Action Obligated Date
Exercise an Option P00008 · Exercise option year 4 - BPA 36E79723A0007 $0
Supplemental Agreement for work within scope P00007 · 2026 public law pricing updates. $0
Exercise an Option P00006 · Exercise option year 3 $0
Supplemental Agreement for work within scope P00005 · 2025 public law pricing updates $0
Exercise an Option P00004 · Exercise option year 2 $0
Supplemental Agreement for work within scope P00003 · 2024 public law pricing updates $0
Exercise an Option P00002 · Exercise option year 1 $0
Supplemental Agreement for work within scope P00001 · 2023 public law pricing updates $0
Original award $0

Quick answers

Who was awarded contract 36E79723A0007?

36E79723A0007 was awarded to Kedrion Biopharma Inc. by National Acquisition Center (Headquarters) on December 6, 2022.

How much is contract 36E79723A0007 worth?

36E79723A0007's own ceiling is $6,358,550.

Who can order from contract 36E79723A0007?

36E79723A0007 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79723A0007 under another contract?

Yes. 36E79723A0007 is a blanket purchase agreement under 36F79719D0242, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79723A0007 competed?

The extent of competition for 36E79723A0007 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV